Nevro Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. I'm Robbie Marcus, the Med Tech analyst at JPMorgan. I'm very happy to have our next session with Nevro. Going to introduce CEO, Keith Grossman. Joining us later for Q&A will also be Rod MacLeod, the CFO; and Julie Tracy -- or sorry, Julie Dewey in Investor Relations, as you all know. So Keith, I'm going to turn it over to you for the presentation. I'll join you in a little bit for some Q&A.
Okay. Sounds good. Thank you, Robbie, and thanks, everyone, for joining us in this time slot and Happy New Year. For those of you who are dialed-in through the JPMorgan portal, we'll go ahead and control the movement of the slides. For those of you who might be following the deck off of our website, I'll try, if I can, to remember to give you slide numbers so you can follow along as well.
All right. Here we go. So I'd refer you to our safe harbor language in our public filings for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
